.AstraZeneca has actually shared an early consider the functionality of its own in-house antibody-dr...
.After announcing a phase 3 launch based upon positive midstage end results, iTeos as well as GSK ar...
.The FDA should be actually more open and also collaborative to let loose a rise in approvals of unc...
.It's an unusually hectic Friday for biotech IPOs, with Zenas BioPharma, MBX as well as Bicara Thera...
.Atea Pharmaceuticals' antiviral has actually fallen short an additional COVID-19 trial, yet the bio...
.Neurocrine Biosciences' schizophrenia program pivot has stopped working. The biotech was unable to ...
.Sanofi has actually made an overdue access to the radioligand event, paying out one hundred thousan...
.After F2G's 1st attempt to receive a brand-new training class of antifungal to market was hindered ...
.Moderna has actually pledged to reduce R&D investing through $1.1 billion by 2027. The decision ...
.Just 4 months after Sanofi bet $80 million in upfront cash on Pivot Therapies' losmapimod, the syst...